Since the first observation of elevated levels of neurofilaments in the cerebrospinal fluid (CSF) of ALS patients,8 extensive work has demonstrated that neurofilament levels, most consistently neurofilament light chain (NfL), are closely associated with measures of disease aggressiveness such as survival and rate of disability progression. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.